In this study, we compared the fertilization rate and embryo quality after intracytoplasmic sperm injection (ICSI) as they relate to oocyte morphology. A total of 654 ICSI cycles yielding 5903 metaphase II oocytes were observed. The oocytes retrieved in these cycles were divided into (i) normal oocytes, (ii) oocytes with extracytoplasmic abnormalities (dark zona pellucida and large perivitelline space), (iii) oocytes with cytoplasmic abnormalities (dark cytoplasm, granular cytoplasm, and refractile body), (iv) oocytes with shape abnormalities, and (v) oocytes with more than one abnormality (double and triple abnormalities). Intracytoplasmic vacuoles and aggregates of smooth endoplasmic reticulum were not recorded separately. The fertilization rate and quality of morphologically graded embryos did not differ between the groups. There were 77 cycles where all transferred embryos were derived from abnormal oocytes, and 164 cycles where all embryos were derived from normal oocytes. These cycles were studied further. The two groups were comparable regarding mean female age, duration of infertility, duration of ovarian stimulation, number of ampoules of gonadotrophin injected, and number of oocytes retrieved. Two clinical pregnancy rates (44.4 versus 42.1%) and implantation rates per embryo (10.3 versus 13.2%) were similar. In conclusion, in couples undergoing ICSI, abnormal oocyte morphology is not associated with a decreased fertilization rate or unfavourable embryo quality. Furthermore, embryos derived from abnormal oocytes yield similar clinical pregnancy and implantation rates when transferred compared with embryos derived from normal oocytes.
Introduction
Abnormal sperm morphology has been associated with failure to fertilize in vitro (Kruger et al., 1986) . Whether the same holds true for oocytes remains unknown. In in-vitro fertilization (IVF), the surrounding cumulus and corona cells prevent accurate assessment of both the maturity and the morphology of the oocyte. However, intracytoplasmic sperm injection (ICSI) offers the unique opportunity to evaluate the naked oocyte and assess whether oocyte morphology affects fertilization. De Sutter et al. (1996) suggested that the morphology of the oocyte bears no relationship to fertilization after ICSI. The pregnancy rate after transfer of morphologically abnormal fertilized oocytes, however, was not available in this study. In a more recent study, Serhal et al. (1997) showed that when transferred, embryos derived from morphologically abnormal oocytes result in poor pregnancy rates. We evaluated the fertilization rate and pregnancy outcome after ICSI of 5903 MII oocytes from 654 ICSI cycles managed with a standard ovarian stimulation protocol.
Materials and methods
The study material consisted of 5903 MII oocytes obtained from 654 ICSI cycles undertaken for male infertility. The data collection period was from January 1997 to September 1997. Only cycles stimulated with a long gonadotrophin-releasing hormone (GnRH) analogue regimen combined with pure follicle-stimulating hormone (FSH) were included in the study. Oocyte retrieval was performed 36 h after the injection of human chorionic gonadotrophin (HCG). Human chorionic gonadotrophin was administered as a single dose of 10 000 IU when the leading follicle reached 20 mm in average diameter in the presence of at least two other follicles of Ͼ18 mm in size. Approximately 2-4 h after retrieval, and following incubation of oocytes in 80 IU/ml hyaluronidase for Ͻ30 s, cumulus-corona cells were stripped off the oocytes with gentle pipetting. The morphology of the oocyte was assessed under an inverted microscope at ϫ200 or ϫ400 magnification (Nikon Diaphot 300 with Hoffman modulation contrast) and the oocytes were grouped as follows: (i) normal morphology, (ii) dark zona pellucida, (iii) dark cytoplasm, (iv) granular cytoplasm, (v) large perivitelline space, (vi) refractile body, (vii) irregular shape, (viii) double anomaly and (ix) triple anomaly. Oocytes were classified according to Veeck et al. (1988) . To simplify this classification, we further divided the oocytes with abnormal morphology into (i) extracytoplasmic abnormalities (dark zona pellucida and large perivitelline space assessed subjectively), (ii) cytoplasmic abnormalities (dark cytoplasm, granular cytoplasm, and refractile body), (iii) shape abnormalities, and (iv) multiple abnormalities (double and triple abnormalities). Intracytoplasmic vacuoles and aggregates of smooth endoplasmic reticulum were not recorded separately.
ICSI was performed according to Van Steirteghem et al. (1993) . Normal fertilization was assumed for oocytes which formed two pronuclei and two polar bodies. The best four embryos assessed morphologically were transferred transcervically~48 h after oocyte retrieval. The embryos were graded for morphology according to Staessen et al. (1992) . Grade 1: even and homogeneous blastomeres without fragmentation; Grade 2: even and homogeneous blastomeres with Ͻ20% fragmentation; Grade 3: uneven and non-homogeneous blastomeres with 20-50% fragmentation; Grade 4: uneven and non- homogeneous blastomeres with Ͼ50% fragmentation. Embryo transfer was performed using the Wallace catheter (Edwards-Wallace Embryo Replacement Catheter ® ; Simcare, Sussex, UK) for straightforward and the Frydman catheter (Set de Frydman Pour Transfert Difficile ® ; Laboratoire CCD, Paris, France) for difficult cases. Transfers were performed with transabdominal ultrasound guidance. All women received 200 mg doxycycline and 16 mg methylprednisolone daily for 5 days starting on the day of oocyte retrieval. The luteal phase was supplemented with intravaginal micronized progesterone (Utrogestan ® ; Laboratories Besins Iscovesco, Paris, France) at a dose of 600 mg daily in three divided doses starting on the day of oocyte retrieval. Pregnancy was defined as two β-HCG titres assessed 12 and 14 days after embryo transfer showing appropriate doubling. Clinical pregnancy was defined as the presence of gestational sac/s with a viable embryo on vaginal ultrasonography performed approximately 4 weeks after embryo transfer.
The fertilization rate, embryonic quality and clinical pregnancy rates were determined in relation to oocyte morphology. Analysis of variance with Bonferroni post-hoc test and χ 2 test was used for statistical analysis of the results. Significance was accepted at P Ͻ 0.05.
Results
From 654 ICSI cycles, 7506 oocytes including 5903 metaphase II oocytes were retrieved. Of these oocytes, 3723 (63.1%) had at least one demonstrable morphological abnormality. Abnormalities of the zona pellucida and perivitelline space were encountered in 36.5% of these oocytes (Figure 1 ). Cytoplasmic abnormalities (dark cytoplasm, granular cytoplasm and refractile bodies) were seen in 25.3% of the oocytes (Figure 1 ). Abnormalities regarding shape occurred in 5.9% (Figure 2 ) and the remaining 31.9% showed more than one (double or triple) abnormality (Table I) . As is evident from Table II normal and the various categories of abnormal oocytes did not differ regarding fertilization and cleavage rates (P Ͼ 0.05). Furthermore, embryos derived from normal and abnormal oocytes were morphologically similar.
There were 77 transfer cycles in which all the transferred embryos were derived from morphologically abnormal oocytes and 164 transfer cycles in which all embryos were derived from morphologically normal oocytes (Table III) . These two groups did not differ from each other regarding mean female age, duration of infertility, duration of ovarian stimulation, number of gonadotrophin ampoules injected, and mean number of oocytes retrieved (P Ͼ 0.05). Furthermore, the clinical pregnancy and implantation rates were also similar (Table III) .
Discussion
Our results clearly indicate that oocyte morphology does not unfavourably alter the fertilization and cleavage rates after ICSI. The above statement includes oocytes with cytoplasmic, extracytoplasmic and shape abnormalities. The impact of oocyte morphology on pregnancy rates, however, is less clear as only cycles with all transferred embryos resulting from morphologically abnormal oocytes should be analysed to show a cause and effect relationship. In our study there were 77 such transfer cycles. When these cycles were compared with 164 transfer cycles where all embryos were derived from normal oocytes, there was no difference regarding mean female age, duration of infertility and stimulation characteristics (duration of stimulation, number of gonadotrophin ampoules injected and number of oocytes retrieved). Furthermore, the clinical pregnancy rate (44.4 versus 42.1%) and implantation rate per embryo (10.3 versus 13.2%) were also similar (Table III) .
Results from IVF cycles show that oocytes with cytoplasmic abnormalities such as dark and granular cytoplasm and refractile bodies show poor fertilization rates (Veeck, 1991) . Values in parentheses are percentages. There were no significant differences between the two groups. HCG ϭ human chonionic gonadotrophin.
Oocyte morphology and ICSI
Abnormal oocyte morphology has been associated with ovarian stimulation, the hormonal environment to which the gametes are exposed, and the chromosomal constitution of the oocyte itself. As all of the cycles studied here received a standardized GnRH analogue and gonadotrophin protocol, differences in morphology cannot be related to ovarian stimulation. Chromosomal analysis of normal and abnormal oocytes that failed to fertilize may delineate whether there are genetic defects associated with abnormal oocyte morphology. Oocytes with abnormal cytoplasmic morphology were shown to have a high frequency of aneuploidy (Van Blerkom and Henry, 1992) . However, there is no study comparing the genetics of oocytes with normal and abnormal morphology. Furthermore, it is not known which morphological abnormality is associated with a higher incidence of chromosomal aberrations. In this study, the fact that cytoplasmic vacuoles and aggregates of smooth endoplasmic reticulum were not specifically segregated may have influenced the results. Separate analysis of such oocytes and embryos derived from them may have shown poorer fertilization rates and inferior embryo quality.
As it overcomes almost all barriers to fertilization, oocytes otherwise destined to remain unfertilized after IVF will fertilize after ICSI. Fertilization appears to be unrelated to oocyte morphology. Furthermore, embryos derived from abnormal oocytes appear to be endowed with a similar capacity to implant into the uterus.
